Drug repurposing in amyotrophic lateral sclerosis (ALS).
Carroll E. et al, (2025), Expert Opin Drug Discov, 1 - 18
Phenomics-based Discovery of Novel Orthosteric Choline Kinase Inhibitors.
Bauer LG. et al, (2024), Angew Chem Int Ed Engl
Toward target 2035: EUbOPEN - a public-private partnership to enable & unlock biology in the open.
Tredup C. et al, (2024), RSC Med Chem
Paralogue-Selective Degradation of the Lysine Acetyltransferase EP300
Chen X. et al, (2024), JACS Au
Unexpected Noncovalent Off-Target Activity of Clinical BTK Inhibitors Leads to Discovery of a Dual NUDT5/14 Antagonist.
Balıkçı E. et al, (2024), J Med Chem, 67, 7245 - 7259
Discovery of PFI-6, a small-molecule chemical probe for the YEATS domain of MLLT1 and MLLT3.
Raux B. et al, (2024), Bioorg Med Chem Lett, 98
Advancing drug discovery through assay development: a survey of tool compounds within the human solute carrier superfamily.
Digles D. et al, (2024), Front Pharmacol, 15
Target deconvolution with matrix-augmented pooling strategy reveals cell-specific drug-protein interactions.
Ji H. et al, (2023), Cell Chem Biol, 30, 1478 - 1487.e7
Cyclic peptides target the aromatic cage of a PHD-finger reader domain to modulate epigenetic protein function.
Coleman OD. et al, (2023), Chem Sci, 14, 7136 - 7146
Open resources for chemical probes and their implications for future drug discovery.
Balıkçı E. et al, (2023), Expert Opin Drug Discov, 18, 505 - 513
Discovery of a Chemical Probe to Study Implications of BPTF Bromodomain Inhibition in Cellular and in vivo Experiments.
Martinelli P. et al, (2023), ChemMedChem, 18
Discovery of High-Affinity Small-Molecule Binders of the Epigenetic Reader YEATS4.
Londregan AT. et al, (2023), J Med Chem, 66, 460 - 472
Global Assessment of Drug Target Engagement and Selectivity of Covalent Cysteine-Reactive Inhibitors Using Alkyne-Functionalized Probes.
Rothweiler EM. and Huber KVM., (2023), Methods Mol Biol, 2706, 191 - 200
DNA double-strand break-derived RNA drives TIRR/53BP1 complex dissociation.
Ketley RF. et al, (2022), Cell Rep, 41
Covalent fragment-based ligand screening approaches for identification of novel ubiquitin proteasome system modulators.
Rothweiler EM. et al, (2022), Biol Chem, 403, 391 - 402
A chemical biology toolbox to investigate in-cell target engagement and specificity of PRMT5-inhibitors
Rothweiler EM. et al, (2022)
Chemoproteomic Profiling of Covalent XPO1 Inhibitors to Assess Target Engagement and Selectivity.
Martin JG. et al, (2021), Chembiochem, 22, 2116 - 2123
Fragment Screening Reveals Starting Points for Rational Design of Galactokinase 1 Inhibitors to Treat Classic Galactosemia.
Mackinnon SR. et al, (2021), ACS Chem Biol, 16, 586 - 595